INTERNATIONAL PATENT: SHENZHEN GENOCURY BIOTECH CO., LTD, 深圳市济因生物科技有限公司 FILES APPLICATION FOR "SINGLE-DOMAIN ANTIBODY TARGETING CD79B, CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF"

Posted On: 2025-04-05

GENEVA, April 5 -- SHENZHEN GENOCURY BIOTECH CO., LTD (Room 1505, Building 10, Shenzhen Biomedicine Innovations Industrial Park, No. 14, Jinhui Road, Jinsha Community, Kengzi ST., Pingshan DistrictShenzhen, Guangdong 518122), 深圳市济因生物科技有限公司 (中国广东省深圳市坪山区坑梓街道金沙社区金辉路14号深圳市生物医药创新产业园区10号楼1505) filed a patent application (PCT/CN2024/121623) for "SINGLE-DOMAIN ANTIBODY TARGETING CD79B, CHIMERIC ANT...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: SHENZHEN GENOCURY BIOTECH CO., LTD, 深圳市济因生物科技有限公司 FILES APPLICATION FOR "SINGLE-DOMAIN ANTIBODY TARGETING CD79B, CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF"